… An intraclass correlation coefficient was calculated to determine the consistency with
which responseto inhaled albuterol was measured. The magnitude of the albuterol effect on …

… the magnitude … comparing dual bronchodilator therapy versus LABA monotherapy. The
mean difference in FEV 1 improvement from baseline to 12 weeks for dual bronchodilator therapy …

… When interpreting the data, it is important to remember the limitations of comparison … with
salbutamol compared with ipratropium, but the magnitudes of improvement in the CWR cycle …

… on LABA and LAMA bronchodilator therapy (once daily LAMA … combining a single
bronchodilator and inhaled steroid [7]. … Room costs are not visible due to the very small …

… are used “as needed” in asthma management, regular bronchodilator therapy with an …
to be of a greater magnitude in COPD than asthma, although there are few comparisons. …

The role of ipratropium bromide as adjunct therapy to β-agonists in acute asthma is uncertain.
We therefore decided to compare the use of 3 mg of salbutamol sulfate alone vs 3 mg …

… patients from being given a therapeutic trial with salmeterol and theophylline. The magnitude
of bronchodilator response showed no diminution when comparing the area under curve …

… to difficulties in interpreting and comparing the results of acute … threshold 19 and the specific
bronchodilator used. In a study … The magnitude of bronchodilator response to salmeterol or …

… in X5 as a means of measuring bronchodilator responsiveness unsuitable and potentially
misleading in view of the extremely high magnitude of percentage changes, and absolute …

… Both the magnitude and rate of rescue bronchodilation were greater with montelukast … of
montelukast permits a greater and more rapid rescue bronchodilation with a short-acting beta2-…